A rapidly growing biotechnology company that is pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology. Our partner is committed to developing a differentiated class of therapeutics for oncology indications and more.

This influential hire provided development and scientific leadership to programs across the portfolio aimed at developing several highly novel peptide therapeutics. They worked closely with the Head of Clinical Development as well as clinical, translational, discovery and preclinical groups to facilitate early phase studies and development planning. This hire also collaborated with study sites, investigators, advisors and contract research organizations.